206 related articles for article (PubMed ID: 31187185)
1. Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Lee YH
Virchows Arch; 2019 Nov; 475(5):617-624. PubMed ID: 31187185
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Jhuang YL; Chou YH; Lin CY
Histopathology; 2016 Apr; 68(5):641-7. PubMed ID: 26212680
[TBL] [Abstract][Full Text] [Related]
3. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.
Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY
Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350
[TBL] [Abstract][Full Text] [Related]
4. Expression of Mucin 1 in salivary gland tumors and its correlation with clinicopathological factors.
Ma S; An F; Li LH; Lin YY; Wang J
J Biol Regul Homeost Agents; 2019 Mar-Apr,; 33(2):563-569. PubMed ID: 30916513
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of pan-TRK immunohistochemistry in differentiating secretory carcinoma from acinic cell carcinoma of salivary gland-A systematic review.
Sharma P; Sivakumar N; Pandiar D
J Oral Pathol Med; 2023 Mar; 52(3):255-262. PubMed ID: 36207812
[TBL] [Abstract][Full Text] [Related]
6. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.
Klubíčková N; Grossmann P; Šteiner P; Baněčková M; Mosaieby E; Koshyk O; Michal M; Leivo I; Skálová A
Virchows Arch; 2023 Feb; 482(2):339-345. PubMed ID: 36469101
[TBL] [Abstract][Full Text] [Related]
7. MUC4 is a valuable marker for distinguishing secretory carcinoma of the salivary glands from its mimics.
Taverna C; Baněčková M; Lorenzon M; Palomba A; Franchi A; Skalova A; Agaimy A
Histopathology; 2021 Sep; 79(3):315-324. PubMed ID: 32931030
[TBL] [Abstract][Full Text] [Related]
8. [Expression of NR4A3/NOR-1 in acinic cell carcinoma of the salivary gland].
Cheng K; Wang X; Wei X; Ma J; Xia QY; Shi QL; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1142-1146. PubMed ID: 33152819
[No Abstract] [Full Text] [Related]
9. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
Hung YP; Jo VY; Hornick JL
Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of acinic cell carcinoma of the salivary gland on cytology specimens: Role of NOR-1 (NR4A3) immunohistochemistry.
Meiklejohn K; Hrones M; Wang M; Prasad ML; Cai G; Adeniran A; Gilani SM
Cytopathology; 2023 May; 34(3):219-224. PubMed ID: 36825365
[TBL] [Abstract][Full Text] [Related]
11. Identification of LMO2 as a new marker for acinic cell carcinoma of salivary gland.
Sheng D; Zhang Y; Xue T; Zhou XY; Li XQ
Diagn Pathol; 2022 Jan; 17(1):15. PubMed ID: 35094691
[TBL] [Abstract][Full Text] [Related]
12. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
[TBL] [Abstract][Full Text] [Related]
13. Defining the relationship of salivary gland malignancies to novel cell subpopulations in human salivary glands using single nucleus RNA-sequencing.
Nakagawa T; Santos J; Nasamran CA; Sen P; Sadat S; Monther A; Bendik J; Ebisumoto K; Hu J; Preissl S; Guo T; Vavinskaya V; Fisch KM; Califano JA
Int J Cancer; 2024 Apr; 154(8):1492-1503. PubMed ID: 37971144
[TBL] [Abstract][Full Text] [Related]
14. DOG1: a novel marker of salivary acinar and intercalated duct differentiation.
Chênevert J; Duvvuri U; Chiosea S; Dacic S; Cieply K; Kim J; Shiwarski D; Seethala RR
Mod Pathol; 2012 Jul; 25(7):919-29. PubMed ID: 22460810
[TBL] [Abstract][Full Text] [Related]
15. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
[TBL] [Abstract][Full Text] [Related]
16. Secretory carcinoma of the breast: a tumour analogous to salivary gland acinic cell carcinoma?
Hirokawa M; Sugihara K; Sai T; Monobe Y; Kudo H; Sano N; Sano T
Histopathology; 2002 Mar; 40(3):223-9. PubMed ID: 11895487
[TBL] [Abstract][Full Text] [Related]
17. Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland.
Millan N; Tjendra Y; Zuo Y; Jorda M; Garcia-Buitrago M; Velez-Torres JM; Gomez-Fernandez C
Cancer Cytopathol; 2022 Dec; 130(12):949-954. PubMed ID: 35913415
[TBL] [Abstract][Full Text] [Related]
18. NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens.
Viswanathan K; Beg S; He B; Zhang T; Cantley R; Lubin DJ; Shi Q; Maleki Z; Asiry S; Rao R; Katabi N; Nakaguro M; Faquin WC; Sadow PM; Siddiqui MT; Scognamiglio T
Am J Clin Pathol; 2022 Jan; 157(1):98-108. PubMed ID: 34508546
[TBL] [Abstract][Full Text] [Related]
19. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
[TBL] [Abstract][Full Text] [Related]
20. MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue.
Mannweiler S; Beham A; Langner C
APMIS; 2003 Oct; 111(10):978-84. PubMed ID: 14616551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]